Sep. 10 at 6:29 PM
$XAIR
IRT the actual FDA approval date being on 3 Sep 2025 and the press release date being on 8 Sep 2025. It is normal for a company to wait several days before announcing FDA orphan drug designation news to investors and the public. After the FDA grants an orphan drug designation (as reflected in the public FDA database), a company must internally review the official notice, coordinate legal and PR teams, and prepare an accurate press release—this process commonly takes several days. As for releasing the warrants exercise information, it had to come out before 9 Sep 2025. If it comes before FDA press release, the sh price could drop below
$2.21, and holders will not take the offer.
To be clear, I'm not here to defend, pump, or short XAIR - just to learn about the company issues and their solutions. If XAIR continues to solve their problems, it has potential to grow. IMHO, I feel this is what most investors are focusing on - growth. The share price will always move up and down.
